Egyptian Initial Experience About 2019 Novel Corona Virus: Study of 48 Patients in Alexandria-Egypt Using Chest CT
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04382469|
Recruitment Status : Completed
First Posted : May 11, 2020
Last Update Posted : May 12, 2020
Background: Corona virus disease 2019 (COVID-19) is a highly infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Purpose: To give initial experience about COVID-19 in Alexandria-Egypt describing radiological patterns of lung involvement, also surveying prevalence of co-morbid lung diseases and their effect on COVID-19 presentation.
Methods: Retrospective study including 48 patients with positive polymerase chain reaction (PCR) test for COVID-19 during the period from February 2020 till May 2020 in Alexandria/Egypt. Full clinical and laboratory data are obtained. High resolution computed tomography (HRCT) findings are described. Serial follow up studies are done. Surveying co-morbid lung diseases done including tuberculosis (TB), interstitial lung diseases (ILDs), chronic obstructive lung disease (COPD), immune and vascular-related diseases. Prevalence rate is the predominant analysis.
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||48 participants|
|Official Title:||Egyptian Initial Experience About 2019 Novel Corona Virus Disease (COVID-19): Single-center Study Analysis of 48 Patients in Alexandria-Egypt Regarding Radiological Patterns and Co-morbid Lung Diseases|
|Actual Study Start Date :||February 1, 2020|
|Actual Primary Completion Date :||April 30, 2020|
|Actual Study Completion Date :||May 1, 2020|
- Radiological pattern of initial presentation, disease progress, healing and recovery [ Time Frame: "through study completion, an average of 1 month" ]HRCT findings
- Survey of co-morbid lung diseases [ Time Frame: "through study completion, an average of 1 month" ]prevalence
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04382469
|Faculty of Medicine, University of Alexandria|
|Alexandria, Egypt, 21526|
|Principal Investigator:||Ahmed Samir, MD||Department of Radio-diagnosis.|